Profound Weight Loss: Up to 22.5% body weight reduction in obese individuals over 72 weeks 2
Retatrutide (LY3437943), marketed here as Reta-Solution, is an investigational multi-receptor peptide agonist that targets the receptors for GIP, GLP-1 and glucagon, and is used in experimental models of obesity, glycemic control and metabolic regulation
Clin Kidney J 2022;15:727e37
To attend any of the classes offered at IECSC New York, be sure to register here to attend IECSC New York from March 23-25, 2025
Whether you are on a GLP-1 medication or prefer a natural approach, this patch helps support metabolic health without pills, powders, or side effects
We focus on healthy fats that help activate PPAR-alpha and fat-burning pathways in the body, helping you to burn fat and keeping you feeling satiated on a plant-rich diet